VERI-101

N/A

Report date: 2024/11/08 11:13:18

Base Information

Drug NameVERI-101
Drug Alias NameViPVERI-101VERI-003
ClassificationBiologics
Mechanisms of ActionHLA Class I Histocompatibility Antigen, A-2 alpha Chain modulators
TargetsHLA Class I Histocompatibility Antigen, A-2 alpha Chain
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdVerImmune Inc
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Fosun Pharmaceutical (Group) Co LtdVerImmune Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A